Literature DB >> 10692521

Glycoxidative modification of AA amyloid deposits in renal tissue.

N Uesugi1, N Sakata, R Nagai, T Jono, S Horiuchi, S Takebayashi.   

Abstract

BACKGROUND: N(epsilon)-carboxymethyllysine (CML) is a product of the oxidative modification of glycated proteins, which damages proteins with ageing, diabetes, uraemia and Alzheimer's disease. In contrast, pyrraline is one of the advanced glycation end products, which is independent of oxidative processes. CML has been identified in beta-amyloid of Alzheimer's disease and beta(2)-microglobulin-associated amyloid. We investigated whether CML and pyrraline are formed in AA and AL amyloid of the kidney.
METHOD: Renal specimens from 19 cases of AA amyloidosis and 14 cases of AL amyloidosis were investigated for immunolocalization of CML, pyrraline, collagen type IV and laminin in amyloid deposits. Renal biopsies of 10 age-matched cases with thin basement membrane disease and normal renal function were used as controls. The fractional areas of amyloid, CML, laminin and collagen IV in glomeruli and interstitium (%amyloid, %CML, %laminin and %collagen, respectively) were calculated using the point counting method. The correlation between these parameters was evaluated using Spearman's rank correlation test.
RESULTS: CML colocalized with AA amyloid, but not AL amyloid, except in two cases of the latter with a long history of nephropathy exceeding 14 years. In contrast, pyrraline was not observed in either type of amyloid. Mean %CML in AA amyloid was significantly higher than %collagen and %laminin in glomeruli and interstitium, indicating that AA amyloid is modified by CML independent of colocalized extracellular matrix. %CML significantly correlated with %amyloid both in glomeruli and interstitium in AA amyloidosis. AL amyloid cases with a long history of nephropathy showed positive staining for CML in glomeruli and interstitium but no staining for collagen IV and laminin in amyloid deposits.
CONCLUSION: CML modification may occur in amyloid deposits of AA amyloidosis, independent of extracellular matrix components. Glycoxidative modification may have a functional link to AA amyloid deposition in renal tissues.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692521     DOI: 10.1093/ndt/15.3.355

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

1.  Involvement of Maillard reactions in Alzheimer disease.

Authors:  V Prakash Reddy; Mark E Obrenovich; Craig S Atwood; George Perry; Mark A Smith
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

2.  Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis.

Authors:  Christoph Röcken; Rosemarie Kientsch-Engel; Sophie Mansfeld; Barbara Stix; Kay Stubenrauch; Bernd Weigle; Frank Bühling; Mona Schwan; Wolfgang Saeger
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

Review 3.  The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases.

Authors:  Mieke Steenbeke; Reinhart Speeckaert; Stéphanie Desmedt; Griet Glorieux; Joris R Delanghe; Marijn M Speeckaert
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.